Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01140880 · ClinicalTrials.gov registry record · Phase 2
Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
A Phase 2 study of Stimulant Abuse and HIV Seroconversion, sponsored by Friends Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT01140880 is a Phase 2 study of Stimulant Abuse and HIV Seroconversion that has completed, run by Friends Research Institute. The registered enrollment target is 170 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01140880, a Phase 2 study of Stimulant Abuse and HIV Seroconversion, has completed, sponsored by Friends Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to evaluate the efficacy of a contingency management (CM) intervention compared to a yoked control condition for eliminating illicit stimulant use and for decreasing time to initiating post exposure prophylaxis (PEP), for improving adherence to PEP, and for completing PEP following a potential HIV-exposure event. Men who have sex with men who use cocaine amphetamine or methamphetamine frequently also have high risk sexual behaviors during or after their drug use. The objective of this study evaluates whether the use of CM that targets stimulant use significantly aids men who have sex with men who use stimulants and also engage in high-risk sexual transmission behaviors to be able to initiate, adhere to and complete PEP, thereby optimizing the utility of a biomedical HIV prevention intervention for reducing HIV incidence in this very high-risk group of MSM.
Conditions Studied
Interventions
- DRUG Truvada
Study Locations (1)
California
- Friends Community Center, A Division of Friends Research Institute, Inc. - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2010-05 |
| Est. Completion | 2013-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01140880
The ClinicalTrials.gov registry entry for NCT01140880 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Friends Research Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Stimulant Abuse appearing as the primary indexed condition, and to 1 intervention - of which Truvada is the first listed.
NCT01140880 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01140880 about?
NCT01140880 is a clinical study titled "Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men". This study seeks to evaluate the efficacy of a contingency management (CM) intervention compared to a yoked control condition for eliminating illicit stimulant use and for decreasing time to initiating post exposure prophylaxis (PEP), for improving adherence to PEP, and for completing PEP following ...
What is the current status of trial NCT01140880?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 170 participants. The study started on 2010-05. Estimated completion is 2013-03.
What conditions does trial NCT01140880 study?
This clinical trial studies the following conditions: Stimulant Abuse, HIV Seroconversion.
What interventions are being tested in trial NCT01140880?
The interventions under investigation include: Truvada (DRUG).
Who is sponsoring clinical trial NCT01140880?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01140880 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stimulant Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.